A new study published in the journal of BMC Nephrology revealed that kidney disease (KD) caused by an infection with the ...

A team of UBC experts are spreading knowledge to protect the public from the incurable but preventable disease of measles.

A key viral mechanism that allows HSV-1 to evade the brain’s natural defenses has been uncovered and tested to identify new ...

An interdisciplinary research team involving the German Center for Infection Research (DZIF) has identified two antiviral ...

About 30% of all respiratory tract infections are caused by coronaviruses, leading to widespread illnesses and, in some cases ...

Researchers at the Department of Medicine, Huddinge, have presented new research on how some people with HIV can control the ...

AbbVie has received approval from the U.S. Food and Drug Administration (FDA) for a label expansion for MAVYRET ...

Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its broad-spectrum protease inhibitor CDI-988 will be featured in an oral presentation at the 2025 Military Health System Research Symposium (MHSRS ...

NanoViricides (NNVC) is presenting at the prestigious BIO International Convention on June 16th, showcasing their revolutionary broad-spectrum antiviral platform that could transform how we treat ...

The global market for Genital Herpes Treatment is forecasted to attain USD 2,334.1 million by 2025, expanding at 4.9% CAGR to reach USD 3,772.1 million by 2035. In 2024, the revenue of Genital Herpes ...

Researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering have developed a compound that could work as a ...

The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first ...